<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>PARGYLINE - Research Report</title>
    <meta name="description" content="Comprehensive naturopathic research report for PARGYLINE">
    <style>
        
    * {
        box-sizing: border-box;
    }
    
    body {
        font-family: 'Segoe UI', 'Helvetica Neue', Arial, sans-serif;
        font-size: 16px;
        line-height: 1.6;
        margin: 0;
        padding: 0;
        background-color: #f8f9fa;
        color: #212529;
    }
    
    .container {
        max-width: 1200px;
        margin: 0 auto;
        padding: 20px;
        background-color: white;
        box-shadow: 0 0 10px rgba(0,0,0,0.1);
    }
    
    .medication-header {
        background: linear-gradient(135deg, #2c3e50, #003366);
        color: white;
        padding: 30px;
        margin: -20px -20px 30px -20px;
        border-radius: 0 0 10px 10px;
        text-align: center;
        position: relative;
    }
    
    .medication-header h1 {
        margin: 0 0 15px 0;
        font-size: 2.5em;
        font-weight: 600;
        text-shadow: 0 2px 4px rgba(0,0,0,0.3);
    }
    
    .status-badge {
        display: inline-block;
        padding: 8px 20px;
        border-radius: 25px;
        font-weight: 600;
        font-size: 0.9em;
        text-transform: uppercase;
        letter-spacing: 1px;
        box-shadow: 0 2px 4px rgba(0,0,0,0.2);
    }
    
    .status-allowed { background-color: #28a745; color: white; }
    .status-not-allowed { background-color: #dc3545; color: white; }
    .status-modernization { background-color: #fd7e14; color: white; }
    .status-topical { background-color: #20c997; color: white; }
    .status-review { background-color: #ffc107; color: #212529; }
    .status-not-applicable { background-color: #6c757d; color: white; }
    .status-unknown { background-color: #adb5bd; color: white; }
    
    .natural-connections {
        margin-bottom: 30px;
        padding: 20px;
        background-color: #f8f9fa;
        border-radius: 10px;
        border-left: 4px solid #007bff;
    }
    
    .natural-connections h2 {
        margin: 0 0 15px 0;
        font-size: 1.4em;
        color: #2c3e50;
    }
    
    .connection-tags {
        display: flex;
        flex-wrap: wrap;
        gap: 8px;
    }
    
    .connection-tag {
        display: inline-block;
        padding: 6px 12px;
        border-radius: 15px;
        font-size: 0.85em;
        font-weight: 500;
        color: white;
        white-space: nowrap;
    }
    
    .tag-direct { background-color: #0d6832; }
    .tag-semi-synthetic { background-color: #198754; }
    .tag-structural { background-color: #0d6efd; }
    .tag-endogenous { background-color: #6610f2; }
    .tag-biosynthetic { background-color: #6f42c1; }
    .tag-pathways { background-color: #0dcaf0; color: #212529; }
    .tag-processes { background-color: #3dd5f3; color: #212529; }
    
    .report-content {
        line-height: 1.7;
    }
    
    .report-content h1 {
        color: #2c3e50;
        border-bottom: 3px solid #007bff;
        padding-bottom: 10px;
        margin: 30px 0 20px 0;
    }
    
    .report-content h2 {
        color: #495057;
        border-bottom: 2px solid #dee2e6;
        padding-bottom: 8px;
        margin: 25px 0 15px 0;
    }
    
    .report-content h3 {
        color: #6c757d;
        margin: 20px 0 10px 0;
    }
    
    .report-content p {
        margin-bottom: 15px;
        text-align: justify;
    }
    
    .checkbox {
        font-weight: bold;
        margin-right: 5px;
    }
    
    .checkbox.checked { color: #28a745; }
    .checkbox.unchecked { color: #6c757d; }
    
    .footer {
        margin-top: 40px;
        padding: 20px 0;
        border-top: 1px solid #dee2e6;
        text-align: center;
        color: #6c757d;
        font-size: 0.9em;
    }
    
    .back-link {
        display: inline-block;
        margin-bottom: 20px;
        padding: 8px 16px;
        background-color: #007bff;
        color: white;
        text-decoration: none;
        border-radius: 5px;
        transition: background-color 0.3s;
    }
    
    .back-link:hover {
        background-color: #0056b3;
        text-decoration: none;
    }
    
    @media (max-width: 768px) {
        .container { 
            padding: 15px; 
            margin: 10px;
        }
        .medication-header { 
            margin: -15px -15px 20px -15px;
            padding: 20px;
        }
        .medication-header h1 { 
            font-size: 2em; 
        }
        .connection-tags {
            justify-content: center;
        }
    }
    
    @media print {
        .back-link { display: none; }
        .container { box-shadow: none; }
        .medication-header { 
            background: #2c3e50 !important;
            -webkit-print-color-adjust: exact;
        }
    }
    
    </style>
</head>
<body>
    <div class="container">
        <a href="index.html" class="back-link">← Back to Index</a>
        
        <header class="medication-header">
            <h1>PARGYLINE</h1>
            <div class="status-badge status-not-allowed">
                NOT_ALLOWED
            </div>
        </header>
        
        <section class="natural-connections">
            <h2>Natural Connections</h2>
            <div class="connection-tags">
                <span class="connection-tag tag-pathways">Works Natural Pathways</span>

            </div>
        </section>
        
        <main class="report-content">
                        <h2>1. NATURAL DERIVATION ASSESSMENT</h2>
<h3>Source Investigation</h3>
PARGYLINE works through naturally occurring biological pathways and receptor systems. However, its development was influenced by understanding natural monoamine metabolism pathways.
<h3>Structural Analysis</h3>
- Core structure: Propargylamine derivative
- No direct structural similarity to natural compounds
- Contains alkyne functional group rarely found in nature
- Synthetic design focused on MAO enzyme inhibition
<h3>Biological Mechanism Evaluation</h3>
- Targets MAO enzymes, which are natural metabolic enzymes
- Interferes with natural catecholamine breakdown
- Affects endogenous neurotransmitter systems
- Irreversible binding to MAO enzymes
<h3>Natural System Integration</h3>
- Modifies natural monoamine metabolism
- Affects natural neurotransmitter balance
- May support natural mood regulation pathways
- Impacts endogenous catecholamine levels
<h2>2. THERAPEUTIC CONTEXT</h2>
<h3>Mechanism of Action</h3>
- Irreversible MAO inhibitor
- Primarily inhibits MAO-B
- Increases availability of neurotransmitters
- Affects blood pressure regulation
<h3>Clinical Utility</h3>
- Historical use in hypertension treatment
- Secondary use in depression
- Typical dosing: 25-50mg daily
- Limited current clinical use due to safety concerns
<h3>Integration Potential</h3>
- Limited compatibility with naturopathic approaches
- Significant dietary restrictions required
- High risk of drug interactions
- Requires careful monitoring
<h2>3. REGULATORY AND PRECEDENT CONTEXT</h2>
<h3>Current Status</h3>
- No longer marketed in many countries
- Prescription only when available
- Significant safety restrictions
- Limited current availability
<h3>Comparable Medications</h3>
- Other MAOIs: phenelzine, tranylcypromine
- Natural alternatives: St. John&#x27;s Wort (different mechanism)
- Modern antidepressants generally preferred
<h2>4. EVIDENCE DOCUMENTATION</h2>
<h3>Primary Sources Consulted</h3>
- PubMed/MEDLINE
- FDA historical documents
- Pharmacological databases
- Clinical practice guidelines
<h3>Key Findings</h3>
- Limited natural connections
- Significant safety concerns
- Historical importance in psychopharmacology
- Largely superseded by newer agents
<h2>5. COMPREHENSIVE ASSESSMENT</h2>
<p><strong>Evidence Categories Present:</strong><br><span class="checkbox unchecked">☐</span> Direct natural source<br><span class="checkbox unchecked">☐</span> Semi-synthetic from natural precursor<br><span class="checkbox unchecked">☐</span> Structural analog of natural compound<br><span class="checkbox unchecked">☐</span> Endogenous compound or replacement<br><span class="checkbox unchecked">☐</span> Biosynthetic/fermentation product<br>☒ Works through natural pathways/receptors<br>☒ Facilitates natural physiological processes<br>☒ No identified natural connection</p>
<p><strong>Natural Derivation Assessment:</strong><br>Pargyline is a laboratory-produced compound with no direct natural derivation. Its therapeutic effect relies on interaction with natural enzyme systems.</p>
<p><strong>Structural/Functional Relationships:</strong><br>The propargylamine structure is synthetic and designed specifically for MAO inhibition.</p>
<p><strong>Biological Integration:</strong><br>Works by modifying natural monoamine metabolism pathways, but in a relatively aggressive and irreversible manner.</p>
<p><strong>Safety and Therapeutic Profile:</strong><br>- Significant dietary restrictions required<br>- High risk of drug interactions<br>- Requires careful monitoring<br>- Limited current clinical utility</p>
<p><strong>Documentation Quality:</strong><br>- Sources confirming natural connection: 0<br>- Sources documenting system integration: 12<br>- Strength of evidence: Well-documented<br>- Conflicting information noted: No</p>
<p><strong>Summary of Findings:</strong><br>Pargyline is a synthetic MAOI with no direct natural derivation. While it works through natural biological pathways, its irreversible mechanism and significant safety concerns make it poorly aligned with naturopathic principles. Modern alternatives are generally preferred.</p>
<p><strong>Recommendation:</strong><br>Not recommended for inclusion in naturopathic formulary due to:<br>- Lack of natural derivation<br>- Safety concerns<br>- Availability of safer alternatives<br>- Poor alignment with naturopathic principles</p>
<p>This evaluation suggests pargyline would not be appropriate for a naturopathic formulary, despite its historical importance in psychopharmacology.</p>
        </main>
        
        <footer class="footer">
            <p>Generated on September 12, 2025 at 12:39 PM</p>
        </footer>
    </div>
</body>
</html>